Indian drug manufacturer Morepen Laboratories has begun the production of Russian Sputnik V coronavirus vaccine, the Russian Direct Investment Fund (RDIF), responsible for marketing the shot internationally, has said.

The first test batch made by the Indian manufacturer in the state of Himachal Pradesh will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, Reuters quoted the RDIF as saying.